SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

12 Aug 2022 Evaluate
The sales slipped to Rs. 844.55 millions for the June 2022 quarter as against Rs. 1088.84 millions during the year-ago period.Net profit was down at Rs. 10.53  millions against Rs. 127.86 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -91.76%.The company reported a degrowth in operating Profit to 119.26 millions from 286.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 844.55 1088.84 -22.44 844.55 1088.84 -22.44 3879.61 3728.22 4.06
Other Income 38.98 10.72 263.62 38.98 10.72 263.62 75.26 66.18 13.72
PBIDT 119.26 286.45 -58.37 119.26 286.45 -58.37 834.63 1003.36 -16.82
Interest 45.16 41.80 8.04 45.16 41.80 8.04 172.26 180.75 -4.70
PBDT 74.10 244.65 -69.71 74.10 244.65 -69.71 662.37 822.61 -19.48
Depreciation 62.04 54.62 13.58 62.04 54.62 13.58 236.74 190.31 24.40
PBT 12.06 190.03 -93.65 12.06 190.03 -93.65 425.63 632.30 -32.69
TAX 1.53 62.17 -97.54 1.53 62.17 -97.54 123.25 112.60 9.46
Deferred Tax -1.03 28.97 -103.56 -1.03 28.97 -103.56 49.18 0.03 163833.33
PAT 10.53 127.86 -91.76 10.53 127.86 -91.76 302.38 519.70 -41.82
Equity 144.24 144.24 0.00 144.24 144.24 0.00 144.24 144.24 0.00
PBIDTM(%) 14.12 26.31 -46.32 14.12 26.31 -46.32 21.51 26.91 -20.06

Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×